JPH05317405A - Anti-mildew treatment method for hydraulic calcium phosphate cement curing liquid - Google Patents

Anti-mildew treatment method for hydraulic calcium phosphate cement curing liquid

Info

Publication number
JPH05317405A
JPH05317405A JP4124859A JP12485992A JPH05317405A JP H05317405 A JPH05317405 A JP H05317405A JP 4124859 A JP4124859 A JP 4124859A JP 12485992 A JP12485992 A JP 12485992A JP H05317405 A JPH05317405 A JP H05317405A
Authority
JP
Japan
Prior art keywords
calcium phosphate
liquid
hydraulic
phosphate cement
holding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP4124859A
Other languages
Japanese (ja)
Inventor
Masahiro Hirano
昌弘 平野
Hiroyasu Takeuchi
啓泰 竹内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Materials Corp
Original Assignee
Mitsubishi Materials Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Materials Corp filed Critical Mitsubishi Materials Corp
Priority to JP4124859A priority Critical patent/JPH05317405A/en
Publication of JPH05317405A publication Critical patent/JPH05317405A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)

Abstract

PURPOSE:To enable the blocking of the generation of mildew for a lone time by repeating plural times a process of holding a hydraulic calcium phosphate cement curing liquid containing water soluble saccharides with a specified pH under a dry condition at a specified temperature for a specified period of time. CONSTITUTION:Phosphoric acid, citric acid, sodium carbonate, sodium hydroxide and the like are added to a hydraulic calcium phosphate cement curing liquid to control a pH value thereof to a range of 4.0-10.0. The hydraulic liquid with this range of pH is held under a dry condition to meet treating requirements of 50-90 deg. and 30-120min. Anti-milldew treatment is performed by repeating this holding process a plurality of times. In the heating treatment under the dry condition, it is preferable that the hydraulic liquid is preserved in a dry container set to 50-90 deg.C together with a heat resisting container or others. The heating holding treatment under the dry condition is repeated two to eight times preferably. A sample of the water soluble polysaccharides to be added to the hydraulic liquid is chitin, chitosan or soluble starch or the like.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、生体用セメント、特に
歯科用セメントとして有用な水硬性リン酸カルシウムセ
メントを硬化するために用いるセメント硬化液の抗かび
処理方法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an antifungal treatment method for a cement hardening liquid used for hardening a cement for living body, particularly a hydraulic calcium phosphate cement useful as a dental cement.

【0002】[0002]

【従来の技術】水硬性リン酸カルシウムセメントは、中
性域で練和反応が進行し、セメント硬化体を形成し、硬
化後アパタイトに転化することから、医科歯科用セメン
トとして有用であることが知られている。前記練和反応
の際に用いる硬化液としては、水でも十分であるが、練
和したセメントペーストの流動性及び充填性を向上させ
るために、水溶性高分子を含有する硬化液を用いること
が好ましく、特に生体親和性に優れるコンドロイチン硫
酸ナトリウム等の多糖類を含有する硬化液が提案されて
いる(特開平3−141955)。しかしながら、該硬
化液は、保存中にかびが発生し、腐敗しやすいという問
題がある。抗かび方法としては、冷暗所保存、滅菌処理
等があるが、前者では長期間の保存が困難であり、また
後者では使用後の残存硬化液を再使用する際に、再度滅
菌する必要があり、この際多糖類が熱変性を生じやすい
ので、オートクレーブ滅菌、γ線滅菌、乾燥滅菌等を行
うことはできず、濾過滅菌を行おうとしても少量の場合
が多く、フィルターを通過するには到らない。
2. Description of the Related Art Hydraulic calcium phosphate cement is known to be useful as a cement for medical and dental purposes because it undergoes a kneading reaction in a neutral region to form a hardened cement, which is converted to apatite after hardening. ing. As the curing liquid used in the kneading reaction, water is also sufficient, but in order to improve the fluidity and filling of the kneaded cement paste, it is preferable to use a curing liquid containing a water-soluble polymer. A hardening liquid containing a polysaccharide such as sodium chondroitin sulfate, which is preferably excellent in biocompatibility, has been proposed (JP-A-3-141955). However, the curing liquid has a problem that mold is generated during storage and it is easily decomposed. Antifungal methods include cold and dark storage, sterilization treatment, etc., but the former is difficult to store for a long time, and the latter requires re-sterilization when reusing the residual curing liquid after use, At this time, the polysaccharide is apt to undergo thermal denaturation, and therefore autoclave sterilization, γ-ray sterilization, dry sterilization, etc. cannot be carried out. Absent.

【0003】そこで、抗菌剤を含有する水硬性リン酸カ
ルシウムセメント硬化液が提案されている(特開平3−
267067)。しかしながら、該硬化液に含有される
抗菌剤自体が、生体に対する毒性を有するため、水硬性
リン酸カルシウムセメントの生体親和性を損ない、且つ
硬化した水硬性リン酸カルシウムセメントの物性値が低
下するという問題がある。
Therefore, a hydraulic calcium phosphate cement hardening liquid containing an antibacterial agent has been proposed (JP-A-3-
267067). However, since the antibacterial agent itself contained in the hardening liquid has toxicity to the living body, there is a problem that the biocompatibility of the hydraulic calcium phosphate cement is impaired and the physical properties of the hardened hydraulic calcium phosphate cement are lowered.

【0004】[0004]

【発明が解決しようとする課題】本発明の目的は、かび
の発生を長期間にわたり阻止することのできる保存性に
優れる水硬性リン酸カルシウムセメント硬化液の抗かび
処理方法を提供することにある。
SUMMARY OF THE INVENTION It is an object of the present invention to provide an antifungal treatment method for a hydraulic calcium phosphate cement hardening liquid which is capable of preventing the development of mold for a long period of time and has excellent storage stability.

【0005】また本発明の別の目的は、簡便にかつ少量
でも処理でき、処理後も稠度、粘性等の作業性、硬化条
件に悪影響を与えることのない水硬性リン酸カルシウム
セメント硬化液の抗かび処理方法を提供することにあ
る。
Another object of the present invention is antifungal treatment of a hydraulic calcium phosphate cement hardening liquid which can be easily and small amount treated and does not adversely affect workability such as consistency and viscosity and hardening conditions after the treatment. To provide a method.

【0006】更にまた本発明の別の目的は、リン酸カル
シウムセメント硬化体の物性に悪影響を与えない水硬性
リン酸カルシウムセメント硬化液の抗かび処理方法を提
供することにある。
Still another object of the present invention is to provide an antifungal treatment method for a hydraulic calcium phosphate cement hardening liquid which does not adversely affect the physical properties of the calcium phosphate cement hardening product.

【0007】[0007]

【課題を解決するための手段】本発明によれば、水溶性
多糖類を含有するpH値4.0〜10.0の水硬性リン
酸カルシウムセメント硬化液を、乾燥状態にて、保持温
度50〜90℃、保持時間30〜120分の処理条件下
に保持する工程を、複数回繰返し行うことを特徴とする
水硬性リン酸カルシウムセメント硬化液の抗かび処理方
法が提供される。
According to the present invention, a water-soluble polysaccharide hardening cement of calcium hydroxide phosphate having a pH value of 4.0 to 10.0 and a holding temperature of 50 to 90 in a dry state is used. There is provided a method for antifungal treatment of a hydraulic calcium phosphate cement hardening liquid, which is characterized in that the step of holding under treatment conditions of 30 ° C. and a holding time of 30 to 120 minutes is repeated a plurality of times.

【0008】以下、本発明を詳細に説明する。The present invention will be described in detail below.

【0009】本発明の抗かび処理方法に用いる水硬性リ
ン酸カルシウムセメント硬化液は、特定域のpH値を有
し、水溶性多糖類を含有する水硬性リン酸カルシウムセ
メント硬化液である。前記特定域のpH値としては、硬
化させる水硬性リン酸カルシウムセメントが略中性域で
水和反応して硬化し、また得られるセメント硬化体の生
体刺激性を排除するため、4.0〜10.0の範囲であ
ることが必要である。前記範囲外では、水硬性リン酸カ
ルシウムセメントの硬化が著しく遅延し、また得られる
セメント硬化体の物性が低下し、生体刺激性がある。前
記pH値を調整するには、例えばリン酸、クエン酸、炭
酸水素ナトリウム、水酸化ナトリウム等を添加して、所
望のpHとすることができる。
The hydraulic calcium phosphate cement hardening liquid used in the antifungal treatment method of the present invention is a hydraulic calcium phosphate cement hardening liquid having a pH value in a specific range and containing a water-soluble polysaccharide. The pH value in the specific range is 4.0 to 10 because the hydraulic calcium phosphate cement to be hardened is hardened by the hydration reaction in a substantially neutral range and the biostimulation of the obtained hardened cement is eliminated. It must be in the 0 range. Outside the above range, the setting of the hydraulic calcium phosphate cement will be significantly delayed, and the physical properties of the obtained cement hardened product will be deteriorated, resulting in biostimulation. In order to adjust the pH value, for example, phosphoric acid, citric acid, sodium hydrogen carbonate, sodium hydroxide or the like can be added to obtain a desired pH.

【0010】水硬性リン酸カルシウムセメント硬化液の
成分として用いる水溶性多糖類は、練和時におけるセメ
ントペーストの流動性及び充填性を向上させる成分であ
り、生体親和性に優れる生体高分子であれば特に限定さ
れるものではないが、具体的には例えば、キチン、キト
サン、溶性デンプン、グリコーゲン、アルギン酸、コン
ドロイチン硫酸、ヒアルロン酸及びこれらの塩等を好ま
しく挙げることができる。前記水溶性多糖類の含有割合
は、硬化液に所望の稠度、粘度等を付与し得る程度か
ら、流動性を損なわない程度の範囲であればよく、特に
硬化液全体に対して1〜30重量%の範囲であることが
望ましい。
The water-soluble polysaccharide used as a component of the hydraulic calcium phosphate cement hardening liquid is a component for improving the fluidity and filling property of the cement paste during kneading, and is particularly preferable as long as it is a biopolymer having excellent biocompatibility. Specific examples thereof include, but are not limited to, chitin, chitosan, soluble starch, glycogen, alginic acid, chondroitin sulfate, hyaluronic acid, and salts thereof. The content ratio of the water-soluble polysaccharide may be within a range that can impart desired consistency, viscosity, etc. to the curing liquid, and does not impair fluidity, and is particularly 1 to 30 wt% with respect to the entire curing liquid. It is preferably in the range of%.

【0011】本発明の水硬性リン酸カルシウムセメント
硬化液の抗かび処理方法は、前述の水硬性リン酸カルシ
ウムセメント硬化液を乾燥状態にて、特定の保持温度に
て、特定の時間保持することを、特定回数繰返し行うこ
とを特徴とする。
The antifungal treatment method of the hydraulic calcium phosphate cement hardening liquid of the present invention is carried out by holding the above-mentioned hydraulic calcium phosphate cement hardening liquid in a dry state at a specific holding temperature for a specific number of times. It is characterized by being repeated.

【0012】本発明の抗かび処理方法は乾燥状態にて行
わなければならない。前記乾燥状態とは特に乾燥処理を
必要とするものではなく、また特に湿度付与を必要とし
ない、通常の室内にて処理できることを意味する。好ま
しくは、RH0〜60%の範囲であることが望ましい。
The antifungal treatment method of the present invention must be carried out in a dry state. The dry state does not require a drying treatment and means that the treatment can be performed in an ordinary room which does not require a humidity. Preferably, the range of RH is 0 to 60%.

【0013】本発明の抗かび処理方法により、水硬性リ
ン酸カルシウムセメント硬化液を処理するには、まず硬
化液を保持温度50〜90℃、好ましくは60〜80
℃、保持時間30〜120分間の範囲の保持条件下に
て、前述の乾燥状態に保持する。この際、硬化液は耐熱
性容器に収容して処理するのが望ましく、硬化液を容器
ごと、50〜90℃に設定した乾燥器内に保管したり、
ホットプレート上に載置して処理するのが好ましい。ま
た硬化液の入った容器ごと、紙箱等の包装用容器で梱包
したままの状態で、処理してもよい。前記保持温度が5
0℃未満の場合には十分な抗かび効果が得られず、90
℃を超える場合には水硬性リン酸カルシウムセメント硬
化液の変質が生じる。また前記保持時間は30〜120
分間の範囲であれば厳密に固定する必要はなく、硬化液
の種類や保存状態に応じて設定することができるが、概
ね保持温度に依存する。すなわち、保持温度が高いほど
短い保持時間となり、例えば50℃の保持温度では12
0分間、90℃の保持温度では30分間が望ましい。前
記保持条件が高温・長時間になる場合には、水硬性リン
酸カルシウムセメント硬化液の成分である水溶性多糖類
の変性が生じ易く、低温・短時間になる場合には、十分
な抗かび効果が得られない。
In order to treat the hydraulic setting agent for calcium phosphate cement according to the antifungal treatment method of the present invention, first, the holding temperature of the setting solution is 50 to 90 ° C., preferably 60 to 80.
The above-mentioned dry state is maintained under the holding condition of the temperature of 30 to 120 minutes. At this time, it is desirable to store the curing liquid in a heat-resistant container for processing, and store the curing liquid together with the container in a dryer set at 50 to 90 ° C,
It is preferably placed on a hot plate for processing. Further, the treatment may be carried out in the state where it is packaged in a packaging container such as a paper box together with the container containing the curing liquid. The holding temperature is 5
If the temperature is below 0 ° C, a sufficient antifungal effect cannot be obtained,
If the temperature exceeds ℃, the hydraulic calcium phosphate cement hardening liquid will be deteriorated. The holding time is 30 to 120.
Within the range of minutes, it is not necessary to strictly fix it, and it can be set according to the type of the curing liquid and the storage state, but it generally depends on the holding temperature. That is, the higher the holding temperature is, the shorter the holding time is.
0 minutes, 30 minutes is desirable at a holding temperature of 90 ° C. When the holding conditions are high temperature and long time, modification of the water-soluble polysaccharide which is a component of the hydraulic calcium phosphate cement hardening solution is likely to occur, and when low temperature and short time, sufficient antifungal effect is obtained. I can't get it.

【0014】本発明の抗かび処理方法では、前記条件下
に保持する工程を1サイクルとして、複数回、好ましく
は2〜8回、特に好ましくは3〜5回繰返し行うことに
より、所望の抗かび効果を得ることができる。前記繰返
し回数が2回未満では十分な抗かび効果が得られない場
合があり、8回を超える場合には水硬性リン酸カルシウ
ムセメント硬化液の変質を生じ、かつ処理操作が煩雑に
なる場合がある。
In the antifungal treatment method of the present invention, the step of maintaining the above conditions as one cycle is repeated a plurality of times, preferably 2 to 8 times, particularly preferably 3 to 5 times, to obtain a desired antifungal agent. The effect can be obtained. If the number of repetitions is less than 2 times, a sufficient antifungal effect may not be obtained in some cases, and if it exceeds 8 times, deterioration of the hydraulic calcium phosphate cement hardening liquid may occur and the treatment operation may become complicated.

【0015】前記各保持工程間の温度条件及び放置時間
は特に限定されないが、前記水溶性多糖類の熱による変
質を防止し、熱に弱いかび胞子のみを発芽させ、次いで
これを処理するため、前記保持条件下に保持した硬化液
を、乾燥状態で、20〜25℃の温度にて、15時間以
上放置するのが望ましい。
The temperature condition and the standing time between the respective holding steps are not particularly limited, but in order to prevent the water-soluble polysaccharide from being deteriorated by heat and to germinate only heat-sensitive mold spores and then to treat it, It is desirable to leave the curable liquid held under the above holding conditions in a dry state at a temperature of 20 to 25 ° C. for 15 hours or more.

【0016】本発明の水硬性リン酸カルシウムセメント
硬化液を用いて水硬性リン酸カルシウムセメントを硬化
させるには、通常の練和・硬化方法を用いて行うことが
でき、前記硬化液により硬化させることができる水硬性
リン酸カルシウムセメントの主成分としては、具体的に
はα型第3リン酸カルシウム、第4リン酸カルシウム、
β型第3リン酸カルシウム、ヒドロキシアパタイト、第
2リン酸カルシウム2水和物、第1リン酸カルシウム1
水和物及びこれらの混合物等を好ましく挙げることがで
き、特に例えばα型第3リン酸カルシウムと第2リン酸
カルシウム2水和物又は第1リン酸カルシウム1水和物
との混合物、第4リン酸カルシウムと第2リン酸カルシ
ウム2水和物又は第1リン酸カルシウム1水和物との混
合物、β型第3リン酸カルシウム又はヒドロキシアパタ
イトと第1リン酸カルシウム1水和物との混合物等を好
ましく挙げることができる。
The hardening of the hydraulic calcium phosphate cement using the hydraulic calcium phosphate cement hardening liquid of the present invention can be carried out by a conventional kneading and hardening method, and water which can be hardened by the hardening liquid is used. Specific examples of the main component of the hard calcium phosphate cement include α-type tricalcium phosphate, quaternary calcium phosphate,
β-type tricalcium phosphate, hydroxyapatite, dibasic calcium phosphate dihydrate, monobasic calcium phosphate 1
Preferable examples include hydrates and mixtures thereof, and particularly, for example, a mixture of α-type tribasic calcium phosphate and dibasic calcium phosphate dihydrate or monobasic calcium phosphate monohydrate, quaternary calcium phosphate and dibasic calcium phosphate 2 Preferable examples thereof include a hydrate or a mixture with monocalcium phosphate monohydrate, a mixture of β-type tricalcium phosphate or hydroxyapatite and monocalcium phosphate monohydrate, and the like.

【0017】[0017]

【発明の効果】本発明の水硬性リン酸カルシウムセメン
ト硬化液の抗かび処理方法により、優れた長期保存性を
硬化液に付与することができる。また本処理方法は、簡
便にかつ少量でも処理でき、処理後も硬化液の作業性、
硬化条件に悪影響を与えず、硬化体の物性も変化するこ
とがないので、使用期間中においても、適宜、抗かび処
理を行うことができ、硬化液の抗かび状態を保持するこ
とができる。
The antifungal treatment method of the hydraulic calcium phosphate cement hardening liquid of the present invention can impart excellent long-term storability to the hardening liquid. In addition, this treatment method can easily treat even a small amount, and the workability of the curing liquid after treatment can be improved.
Since the curing conditions are not adversely affected and the physical properties of the cured product do not change, the antifungal treatment can be appropriately performed even during the period of use, and the antifungal state of the curable liquid can be maintained.

【0018】[0018]

【実施例】以下、実施例及び比較例に基づき本発明を更
に詳細に説明するが、本発明はこれらに限定されるもの
ではない。
The present invention will be described in more detail based on the following examples and comparative examples, but the present invention is not limited thereto.

【0019】[0019]

【実施例1】コンドロイチン硫酸ナトリウム(和光純薬
社製、特級)2gを水8mlに溶解し20重量%コンド
ロイチン硫酸ナトリウム水溶液(pH6.2)を調製
し、硬化液Aとした。溶性デンプン(和光純薬社製、特
級)1gを水9mlに溶解し10重量%溶性デンプン水
溶液(pH7.0)を調製し、硬化液Bとした。ヒアル
ロン酸ナトリウム(チッソ社製)0.1gを水9.9m
lに溶解し1重量%ヒアルロン酸ナトリウム水溶液(p
H6.3)を調製し、硬化液Cとした。
Example 1 2 g of sodium chondroitin sulfate (manufactured by Wako Pure Chemical Industries, Ltd., special grade) was dissolved in 8 ml of water to prepare a 20 wt% sodium chondroitin sulfate aqueous solution (pH 6.2), which was used as a curing liquid A. 1 g of soluble starch (manufactured by Wako Pure Chemical Industries, Ltd., special grade) was dissolved in 9 ml of water to prepare a 10 wt% soluble starch aqueous solution (pH 7.0), which was used as a hardening liquid B. 0.1 g of sodium hyaluronate (manufactured by Chisso Corporation) was added to 9.9 m of water.
1 wt% sodium hyaluronate aqueous solution (p
H6.3) was prepared and used as a hardening liquid C.

【0020】各硬化液について、乾燥機(商品名「DX
31型」、ヤマト科学社製)を用いて、表1に示す保持
条件にて保持し、次いで室温(20〜25℃)にて20
時間放置する工程を、表1に示す繰返し回数にて繰り返
した。処理直後に日本薬局方記載の無真菌テストを行
い、硬化液の状態を観察した。また表1中、条件(2)
〜(6)については、1か月ごとに容器のキャップを開
封し滅菌状態を破り、3か月経過ごとに同一条件にて抗
かび処理を行い、1年経過後に前記無真菌テストを行
い、硬化液の状態を観察した。結果を表1に示す。
A dryer (trade name "DX
31 type ", manufactured by Yamato Scientific Co., Ltd.) and held under the holding conditions shown in Table 1, and then at room temperature (20 to 25 ° C.) for 20 hours.
The step of leaving for a time was repeated the number of times shown in Table 1. Immediately after the treatment, a fungus-free test described in the Japanese Pharmacopoeia was performed to observe the state of the hardening liquid. Also, in Table 1, condition (2)
About (6), the cap of the container is opened every month to break the sterilized state, antifungal treatment is performed under the same conditions every three months, and the fungus-free test is performed after one year has passed. The state of the curing liquid was observed. The results are shown in Table 1.

【0021】[0021]

【表1】 [Table 1]

【0022】[0022]

【比較例1】コンドロイチン硫酸ナトリウム(和光純薬
社製、特級)1gを水9mlに溶解し10重量%コンド
ロイチン硫酸ナトリウム水溶液(pH6.4)を調製
し、硬化液Dとした。硬化液Dに対して、表2に示す条
件にて抗かび処理を行い、実施例1と同様の無真菌テス
トを行い、硬化液の状態を観察した。結果を表2に示
す。
Comparative Example 1 1 g of sodium chondroitin sulfate (manufactured by Wako Pure Chemical Industries, Ltd., special grade) was dissolved in 9 ml of water to prepare a 10 wt% sodium chondroitin sulfate aqueous solution (pH 6.4), which was used as a curing liquid D. Antifungal treatment was performed on the curing liquid D under the conditions shown in Table 2, and a fungus-free test similar to that of Example 1 was performed to observe the state of the curing liquid. The results are shown in Table 2.

【0023】[0023]

【表2】 [Table 2]

【0024】[0024]

【実施例2】比較例1で調製した硬化液Dを用いて、乾
燥機(商品名「DX31型」、ヤマト科学社製)を用い
て、80℃、30分間の保持条件にて保持し、次いで室
温(20〜25℃)にて20時間放置することを3回繰
返した。
[Example 2] Using the curing liquid D prepared in Comparative Example 1, using a dryer (trade name "DX31 type", manufactured by Yamato Scientific Co., Ltd.), and holding at 80 ° C for 30 minutes, Then, leaving at room temperature (20 to 25 ° C.) for 20 hours was repeated 3 times.

【0025】一方、水硬性リン酸カルシウムセメントと
して、α型第3リン酸カルシウムと第2リン酸カルシウ
ムセメント2水和物(和光純薬社製、特級)とをCa/
P比が1.48となるように混合し、セメント粉材を調
製した。
On the other hand, as hydraulic calcium phosphate cement, α-type tribasic calcium phosphate and dibasic calcium phosphate cement dihydrate (manufactured by Wako Pure Chemical Industries, special grade) were used as Ca /
Cement powder was prepared by mixing so that the P ratio was 1.48.

【0026】次いで、該セメント粉材と前記処理した硬
化液Dとを、粉液比100:40(重量比)の割合にて
練和し、セメントペーストを得た。得られたセメントペ
ーストの稠度をJIST6602標準稠度試験方法に準
拠し、また粘度を「ビスメトロン」(商品名、芝浦シス
テム(株)製、単一円筒型回転粘度計、型式VG−D
H)を用いて測定し、作業性とした。次いで該セメント
ペーストを直径7mm、高さ14mmの円柱状型に充填
し、硬化するまでの時間をJISR5201に準じて測
定し、硬化時間とした。更に得られたセメント硬化体を
37℃の擬似体液中に7日間浸漬した後、取りだし、濡
れたまま「インストロン万能試験機1125型」(商品
名、インストロン社製)を用いて、荷重速度0.5mm
/分にて圧縮強度を測定した。結果を表3に示す。
Next, the cement powder material and the treated hardening liquid D were kneaded at a powder liquid ratio of 100: 40 (weight ratio) to obtain a cement paste. The consistency of the obtained cement paste conforms to the JIST6602 standard consistency test method, and the viscosity is "Vismetron" (trade name, manufactured by Shibaura System Co., Ltd., single cylinder type rotational viscometer, model VG-D).
H) was used for the workability. Next, the cement paste was filled into a cylindrical mold having a diameter of 7 mm and a height of 14 mm, and the time until curing was measured according to JISR5201 and was defined as the curing time. The obtained cement hardened product was dipped in a simulated body fluid at 37 ° C. for 7 days, then taken out, and using a “Instron universal testing machine 1125 type” (trade name, manufactured by Instron Co., Ltd.), a load speed 0.5 mm
The compressive strength was measured at 1 / min. The results are shown in Table 3.

【0027】[0027]

【比較例2】比較例1で調製した硬化液Dを未処理のま
ま用いた以外は、実施例2と同様に行い、セメントペー
ストの作業性、硬化時間、セメント硬化体の圧縮強度を
測定した。結果を表3に示す。
Comparative Example 2 The same operation as in Example 2 was carried out except that the curing liquid D prepared in Comparative Example 1 was used as it was, and the workability of the cement paste, the curing time, and the compressive strength of the cement cured product were measured. .. The results are shown in Table 3.

【0028】[0028]

【表3】 [Table 3]

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 水溶性多糖類を含有するpH値4.0〜
10.0の水硬性リン酸カルシウムセメント硬化液を、
乾燥状態にて、保持温度50〜90℃、保持時間30〜
120分の処理条件下に保持する工程を、複数回繰返し
行うことを特徴とする水硬性リン酸カルシウムセメント
硬化液の抗かび処理方法。
1. A pH value of 4.0 containing a water-soluble polysaccharide.
10.0% hydraulic calcium phosphate cement hardening liquid,
In the dry state, the holding temperature is 50 to 90 ° C, the holding time is 30 to
An antifungal treatment method for a hydraulic calcium phosphate cement hardening liquid, which comprises repeating the step of maintaining the treatment condition for 120 minutes a plurality of times.
JP4124859A 1992-05-18 1992-05-18 Anti-mildew treatment method for hydraulic calcium phosphate cement curing liquid Withdrawn JPH05317405A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4124859A JPH05317405A (en) 1992-05-18 1992-05-18 Anti-mildew treatment method for hydraulic calcium phosphate cement curing liquid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4124859A JPH05317405A (en) 1992-05-18 1992-05-18 Anti-mildew treatment method for hydraulic calcium phosphate cement curing liquid

Publications (1)

Publication Number Publication Date
JPH05317405A true JPH05317405A (en) 1993-12-03

Family

ID=14895868

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4124859A Withdrawn JPH05317405A (en) 1992-05-18 1992-05-18 Anti-mildew treatment method for hydraulic calcium phosphate cement curing liquid

Country Status (1)

Country Link
JP (1) JPH05317405A (en)

Similar Documents

Publication Publication Date Title
DE69619830T2 (en) BIOMATERIAL COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF
US6214048B1 (en) Bone substitute product and method of producing the same
Bigi et al. Effect of added gelatin on the properties of calcium phosphate cement
Wang et al. Influence of anti‐washout agents on the rheological properties and injectability of a calcium phosphate cement
US5152836A (en) Hydraulic calcium phosphate cement composition and cement composition containing hardening liquid
Cherng et al. Effects of hydroxypropyl methylcellulose and other gelling agents on the handling properties of calcium phosphate cement
DE69013833T2 (en) COMPOSITION AND METHOD FOR PREVENTING BONDING BETWEEN BODY TISSUE.
DE68912302T2 (en) HARDENING MATERIAL FOR MEDICAL AND DENTAL USE.
US9050392B2 (en) Hydrogel and biomedical applications thereof
Han et al. β-TCP/MCPM-based premixed calcium phosphate cements
CN109106974B (en) Gel tissue plugging material, preparation method thereof and plugging product
DE102006033167A1 (en) Use of gelatin and a crosslinking agent for the preparation of a crosslinking medical adhesive
EP1734073A2 (en) Process for preparing sterile polysaccharide solutions
EP0807432B1 (en) Process for the production of a medical preparation containing calcium sulphate and a medical preparation containing calcium sulphate
Kamali et al. Effects of chitosan and zirconia on setting time, mechanical strength, and bioactivity of calcium silicate‐based cement
US6051061A (en) Calcium phosphate cements and calcium phosphate cement compositions
US6338752B1 (en) α-TCP/HAP biphasic cement and its preparing process
NL8402534A (en) MATERIAL, SUITABLE FOR USE AS AN IMPLANT MATERIAL IN HUMANS AND ANIMAL TO REPLACE ABSENT BONE TISSUE, AND METHOD FOR PREPARING THE MATERIAL.
US5980625A (en) Calcium phosphate composition and a setting solution therefor
JPH05317405A (en) Anti-mildew treatment method for hydraulic calcium phosphate cement curing liquid
CN113769159A (en) Anhydrous calcium phosphate bone cement and preparation method thereof
JP3000718B2 (en) Drug sustained release calcium phosphate cement
JPH0528629B2 (en)
Onwubu et al. Hydrocolloids in dentistry: A review
JPH0534300B2 (en)

Legal Events

Date Code Title Description
A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 19990803